OptiBiotix Health (GB:OPTI) has released an update.
OptiBiotix Health PLC, a developer of compounds for health and wellness, has announced that all resolutions were passed at their AGM. The company, listed on AIM under the ticker OPTI, is working on products targeting obesity, high cholesterol, diabetes, and skin care. They have partnerships with over twenty food and healthcare companies to integrate their microbiome modulators into various products.
For further insights into GB:OPTI stock, check out TipRanks’ Stock Analysis page.
